NCT07361562
Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT07361562
Title A Study of a Selective ERBB2 Inhibitor (CGT4255), in Patients With Advanced Solid Tumors
Recruitment Recruiting
Gender both
Phase Phase I
Variant Requirements No
Sponsors Cogent Biosciences, Inc.
Indications
Therapies
Age Groups: senior | adult
Covered Countries USA

Facility Status City State Zip Country Details
HonorHealth Research Institute RECRUITING Scottsdale Arizona 85258 United States Details
Mayo Scottsdale RECRUITING Scottsdale Arizona 85281 United States Details
Yale Cancer Center RECRUITING New Haven Connecticut 06510 United States Details
Mayo Jacksonville RECRUITING Jacksonville Florida 32209 United States Details
Northwestern University RECRUITING Chicago Illinois 60611 United States Details
LSU Health Sciences Center School of Medicine RECRUITING New Orleans Louisiana 70803 United States Details
START Midwest RECRUITING Grand Rapids Michigan 49546 United States Details
Mayo Rochester RECRUITING Rochester Minnesota 55905 United States Details
Washington University School of Medicine - Siteman Cancer Center RECRUITING St Louis Missouri 63110 United States Details
START NY Long Island RECRUITING Lake Success New York 11042 United States Details
NYU Langone RECRUITING New York New York 10016 United States Details
Tennessee Oncology RECRUITING Nashville Tennessee 37203 United States Details
NEXT Oncology Texas RECRUITING Austin Texas 78758 United States Details
START Mountain Region RECRUITING West Valley City Utah 84119 United States Details
NEXT Oncology Virginia RECRUITING Fairfax Virginia 22031 United States Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field